Evidence map›Paper›PMID 30670689›Full record

ArticleNature communications2019

The circadian clock components BMAL1 and REV-ERBα regulate flavivirus replication.

Xiaodong Zhuang, Andrea Magri, Michelle Hill, Alvina G Lai, Abhinav Kumar, Srinivasa Bhargav Rambhatla, Claire L Donald, Andrea F Lopez-Clavijo, Simon Rudge, Katherine Pinnick and 15 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Circadian metabolic adaptations to infections.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  13. Time to start taking time seriously: how to investigate unexpected biological rhythms within infectious disease research.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 3 countries.

Xiaodong ZhuangNuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Andrea MagriNuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Michelle HillOxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.
Alvina G LaiNuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Abhinav KumarOxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.
Srinivasa Bhargav RambhatlaInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
Claire L DonaldMRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.ORCID http://orcid.org/0000-0002-4370-0707
Andrea F Lopez-ClavijoThe Babraham Institute, Cambridge CB22 3AT, UK.
Simon RudgeThe Babraham Institute, Cambridge CB22 3AT, UK.
Katherine PinnickOxford Centre for Diabetes Endocrinology Metabolism, University of Oxford, Oxford OX3 9DU, UK.
Wai Hoong ChangNuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Peter A C WingNuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Ryan BrownDepartment of Chemistry, University of Birmingham, Birmingham B15 2TT, UK.
Ximing QinInstitutes of Physical Science and Information Technology, Anhui University, Hefei 230601, China.ORCID http://orcid.org/0000-0003-2496-2434
Peter SimmondsNuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Thomas F BaumertInserm U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg 67000, France.
David RayFaculty of Medical and Human Sciences, University of Manchester, Manchester M13 9PL, UK.ORCID http://orcid.org/0000-0002-4739-6773
Andrew LoudonFaculty of Medical and Human Sciences, University of Manchester, Manchester M13 9PL, UK.
Peter BalfeInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.ORCID http://orcid.org/0000-0002-6246-0876
Michael WakelamThe Babraham Institute, Cambridge CB22 3AT, UK.
Sam ButterworthDivision of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Manchester M13 9NT, UK.
Alain KohlMRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Catherine L JoplingSchool of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
Nicole ZitzmannOxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.ORCID http://orcid.org/0000-0003-1969-4949
Jane A McKeatingNuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK. jane.mckeating@ndm.ox.ac.uk.
University of Oxford · GBBabraham Institute · GBUniversity of Birmingham · GBMRC University of Glasgow Centre for Virus Research · GBUniversity of Manchester · GBAnhui University · CNInserm · FRManchester Academic Health Science Centre · GBUniversity of Nottingham · GB

Funding

European Research Council 671231Medical Research Council G0801976Medical Research Council G1100247Medical Research Council MC_PC_15029Medical Research Council MC_PC_16056Medical Research Council MC_UU_12014/8Medical Research Council MR/K01532X/1Medical Research Council MR/M004821/1Medical Research Council MR/M008908/1Medical Research Council MR/N017552/1Medical Research Council MR/P011853/1Medical Research Council MR/P023576/1Wellcome Trust 107851/Z/15/Z
6 · The paper itself

Abstract

The circadian clock regulates immune responses to microbes and affects pathogen replication, but the underlying molecular mechanisms are not well understood. Here we demonstrate that the circadian components BMAL1 and REV-ERBα influence several steps in the hepatitis C virus (HCV) life cycle, including particle entry into hepatocytes and RNA genome replication. Genetic knock out of Bmal1 and over-expression or activation of REV-ERB with synthetic agonists inhibits the replication of HCV and the related flaviruses dengue and Zika via perturbation of lipid signaling pathways. This study highlights a role for the circadian clock component REV-ERBα in regulating flavivirus replication.

Indexed as

ARNTL Transcription FactorsCell LineCircadian ClocksDengueDengue VirusDNA ReplicationFlavivirusGene Expression RegulationGenes, EssentialHepacivirusHepatitis CHepatocytesHumansNuclear Receptor Subfamily 1, Group D, Member 1ProteomicsRNA, MessengerARNTL Transcription FactorsBMAL1 protein, humanNR1D1 protein, humanNuclear Receptor Subfamily 1, Group D, Member 1RNA, Messenger

Identifiers

PMID30670689
PMCPMC6343007
OpenAlexW2914598045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.